Is CyberArk Stock a Buy, Sell or Hold?
CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…
Buy
75
RNKGF Quote, Financials, Valuation and Earnings
Last price:
$44.25
Seasonality move
:
--
Day range:
$43.40 - $44.25
52-week range:
$20.55 - $53.94
Dividend yield:
0%
P/E ratio:
33.85x
P/S ratio:
2.43x
P/B ratio:
3.38x
Volume:
1.2K
Avg. volume:
1.5K
1-year change:
--
Market cap:
$1.5B
Revenue:
--
EPS (TTM):
$0.61
RENK Group AG Number of Institutional Trades
RENK Group AG Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$564.6M
(Last 6 Months)
Current Institutional Ownership Percentage
15.23%
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$391.4M
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RENK Group AG Institutional Ownership
-
What Percentage Of RNKGF Is Owned by Institutions?
15.23% of RNKGF is owned by institutions.
-
How Many Institutions Own RNKGF Shares?
RENK Group AG stock is owned by 121 institutional shareholders at this time.
-
Have Institutions Been Buying RNKGF Stock?
Yes, institutions have bought 14.3M shares of RNKGF in the last quarter.
-
Have Institutions Been Selling RNKGF Stock?
Yes, institutions have sold 10.8M shares of RNKGF over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
